IBT — International Biotechnology Trust Share News
0.000.00%
FinancialsBalancedSmall Cap
- £324.44m
- £351.23m
- £6.07m
RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company
Intnl. Biotechnology - Compliance with Market Abuse Regulation
RCS - Intnl. Biotechnology - QuotedData's In The HotSeat
Intnl. Biotechnology - Director/PDMR Shareholding
Intnl. Biotechnology - Director/PDMR Shareholding
Intnl. Biotechnology - Holding(s) in Company
RCS - Intnl. Biotechnology - Portfolio company Crinetics acquired by Vertex
RCS - Intnl. Biotechnology - Portfolio company Apogee to be acquired by AbbVie
RCS - Intnl. Biotechnology - GSK to acquire IBT portfolio company Nuvalent
RCS - Intnl. Biotechnology - Results analysis from Kepler Trust Intelligence
Intnl. Biotechnology - Half-year Report
RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company
RCS - Intnl. Biotechnology - Portfolio company KalVista acquired by Chiesi
RCS - Intnl. Biotechnology - Portfolio company Soleno acquired by Neurocrine
RCS - Intnl. Biotechnology - IBT portfolio company Apellis acquired by Biogen
RCS - Intnl. Biotechnology - IBT portfolio company Terns acquired by Merck
RCS - Intnl. Biotechnology - Kepler Trust Intelligence: New Research
RCS - Intnl. Biotechnology - Portfolio company Day One acquired by Servier
Intnl. Biotechnology - Restatement of Net Asset Value(s)